Epilepsy and attention-deficit hyperactivity disorder: Links, risks, and challenges

Amy E. Williams, Julianne M. Giust, William Kronenberger, David Dunn

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Attention-deficit hyperactivity disorder (ADHD) has a prevalence rate of 7%-9% in the general population of children. However, in children with epilepsy, ADHD has been found to be present in 20%-50% of patients. This paper provides a review of ADHD prevalence in pediatric epilepsy populations and reviews data on specific symptom presentation and attention deficits in patients with epilepsy. This paper also reviews evidence-based treatments for ADHD and specifically the treatment of ADHD as a comorbid condition in children with epilepsy.

Original languageEnglish (US)
Pages (from-to)287-296
Number of pages10
JournalNeuropsychiatric Disease and Treatment
Volume12
DOIs
StatePublished - Feb 9 2016

Fingerprint

Attention Deficit Disorder with Hyperactivity
Epilepsy
Population
Pediatrics
Therapeutics

Keywords

  • ADHD
  • Children
  • Epilepsy
  • Seizure disorder

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Epilepsy and attention-deficit hyperactivity disorder : Links, risks, and challenges. / Williams, Amy E.; Giust, Julianne M.; Kronenberger, William; Dunn, David.

In: Neuropsychiatric Disease and Treatment, Vol. 12, 09.02.2016, p. 287-296.

Research output: Contribution to journalArticle

@article{f4816433e554456ebe3d1a978224aaa4,
title = "Epilepsy and attention-deficit hyperactivity disorder: Links, risks, and challenges",
abstract = "Attention-deficit hyperactivity disorder (ADHD) has a prevalence rate of 7{\%}-9{\%} in the general population of children. However, in children with epilepsy, ADHD has been found to be present in 20{\%}-50{\%} of patients. This paper provides a review of ADHD prevalence in pediatric epilepsy populations and reviews data on specific symptom presentation and attention deficits in patients with epilepsy. This paper also reviews evidence-based treatments for ADHD and specifically the treatment of ADHD as a comorbid condition in children with epilepsy.",
keywords = "ADHD, Children, Epilepsy, Seizure disorder",
author = "Williams, {Amy E.} and Giust, {Julianne M.} and William Kronenberger and David Dunn",
year = "2016",
month = "2",
day = "9",
doi = "10.2147/NDT.S81549",
language = "English (US)",
volume = "12",
pages = "287--296",
journal = "Neuropsychiatric Disease and Treatment",
issn = "1176-6328",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Epilepsy and attention-deficit hyperactivity disorder

T2 - Links, risks, and challenges

AU - Williams, Amy E.

AU - Giust, Julianne M.

AU - Kronenberger, William

AU - Dunn, David

PY - 2016/2/9

Y1 - 2016/2/9

N2 - Attention-deficit hyperactivity disorder (ADHD) has a prevalence rate of 7%-9% in the general population of children. However, in children with epilepsy, ADHD has been found to be present in 20%-50% of patients. This paper provides a review of ADHD prevalence in pediatric epilepsy populations and reviews data on specific symptom presentation and attention deficits in patients with epilepsy. This paper also reviews evidence-based treatments for ADHD and specifically the treatment of ADHD as a comorbid condition in children with epilepsy.

AB - Attention-deficit hyperactivity disorder (ADHD) has a prevalence rate of 7%-9% in the general population of children. However, in children with epilepsy, ADHD has been found to be present in 20%-50% of patients. This paper provides a review of ADHD prevalence in pediatric epilepsy populations and reviews data on specific symptom presentation and attention deficits in patients with epilepsy. This paper also reviews evidence-based treatments for ADHD and specifically the treatment of ADHD as a comorbid condition in children with epilepsy.

KW - ADHD

KW - Children

KW - Epilepsy

KW - Seizure disorder

UR - http://www.scopus.com/inward/record.url?scp=84958036302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958036302&partnerID=8YFLogxK

U2 - 10.2147/NDT.S81549

DO - 10.2147/NDT.S81549

M3 - Article

AN - SCOPUS:84958036302

VL - 12

SP - 287

EP - 296

JO - Neuropsychiatric Disease and Treatment

JF - Neuropsychiatric Disease and Treatment

SN - 1176-6328

ER -